Clause 15
;

15.1

(9.4) Promotional material must not imitate the devices, copy, slogans or general layout adopted by other companies in a way that is likely to mislead or confuse.

15.2

(9.5) Promotional material must not include any reference to the Commission on Human Medicines, the Medicines and Healthcare products Regulatory Agency (MHRA) or the licensing authority, unless this is specifically required by the licensing authority.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

15.3

(9.6) Reproductions of official documents must not be used for promotional purposes unless permission has been given in writing by the appropriate body.

15.4

(9.8) Postcards, other exposed mailings, envelopes or wrappers must not carry matter which might be regarded as advertising to the public, contrary to Clause 26.1.

15.5

(9.9) The telephone, text messages, email, faxes, automated calling systems and other digital communications must not be used for promotional purposes, except with the prior permission of the recipient.

15.6

(12.1) Promotional material and activities must not be disguised.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3734/2/23 - Complainant v Valneva Breach: 5.1, 8.1, 12.9, 15.6 No breach: 2, 26.1 Applicable Code: 2021 Received: 10 February 2023 Completed: 04 June 2024 AUTH/3789/7/23 – Complainant v Moderna No breach: 2, 3.1, 5.1, 5.6, 15.5, 15.6 Applicable Code: 2021 Received: 03 July 2023 Completed: 11 September 2024 AUTH/3746/2/23 - Complainant v Moderna Breach: 2, 5.1, 11.2 No breach: 11.1, 15.6 Applicable Code: 2021 Received: 27 February 2023 Completed: 09 August 2024 AUTH/3729/1/23 - Complainant/s v AstraZeneca Breach: 2, 3.1, 5.1, 6.1, 8.1, 26.1 No breach: 2, 3.1, 5.1, 5.2, 6.1, 9.1, 11.1, 12.1, 14.1, 15.6, 17.2, 17.9, 26.1 Applicable Code: 2021 Received: 14 December 2022 Completed: 22 July 2024 AUTH/3765/4/23 - Complainant v Takeda Breach: 12.9 No breach: 5.1, 5.6, 6.1, 11.1, 12.1, 12.9, 12.10, 15.6, 26.4 Applicable Code: 2021 Received: 25 April 2023 Completed: 27 June 2024 AUTH/3771/6/23 - Complainant v GSK No breach: 2, 5.1, 12.1, 15.6 Applicable Code: 2021 Received: 31 May 2023 Completed: 26 June 2024 AUTH/3739/2/23 - Complainant v Valneva UK Limited Breach: 12.1 No breach: 2, 5.1, 8.1, 8.6, 12.1, 12.9, 15.5, 15.6 Applicable Code: 2021 Received: 13 February 2023 Completed: 06 March 2024 AUTH/3708/11/22 - Complainant v GSK Breach: 5.1, 6.1, 6.2 No breach: 2, 5.1, 9.4, 15.6 Applicable Code: 2021 Received: 16 November 2022 Completed: 15 December 2023 AUTH/3702/10/22 - Health Professional v Amgen Breach: 5.1, 10.9 No breach: 2, 15.5, 15.6 Applicable Code: 2021 Received: 27 October 2022 Completed: 09 October 2023 AUTH/3706/11/22 - Complainant v CSL Vifor No breach: 2, 5.1, 15.6, 23.1, 23.2 Applicable Code: 2021 Received: 14 November 2022 Completed: 17 August 2023 AUTH/3711/11/22 - Complainant v Novo Nordisk Breach: 5.1, 5.5 No breach: 2, 3.3, 5.1, 5.5, 8.1, 12.1, 15.6 Applicable Code: 2021 Received: 21 November 2022 Completed: 09 March 2023 AUTH/3578/11/21 - Employee v AstraZeneca Breach: 5.1 No breach: 2, 15.6, 19.1 Applicable Code: 2021 Received: 05 November 2021 Completed: 08 November 2022